These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23979978)

  • 1. Polymorphisms in the MDM2 gene and risk of malignant bone tumors: a meta-analysis.
    Tang J; Shen L; Song S; An Z; Zhang C
    Tumour Biol; 2014 Jan; 35(1):779-84. PubMed ID: 23979978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between MDM2 promoter SNP309 T/G polymorphism and liver cancer risk - a meta-analysis.
    Ma HB; Huang T; Han F; Chen WY
    Asian Pac J Cancer Prev; 2012; 13(6):2841-6. PubMed ID: 22938470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis.
    Wan Y; Wu W; Yin Z; Guan P; Zhou B
    BMC Cancer; 2011 May; 11():208. PubMed ID: 21619694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine Double Minute 2 SNP T309G Polymorphism and Urinary Tract Cancer Risk: A Meta-Analysis.
    Ding H; Dai Y; Ning Z; Fan N; Wang Z; Li P; Zhang L; Tao Y; Wang H
    Medicine (Baltimore); 2016 Mar; 95(12):e2941. PubMed ID: 27015167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis.
    Ma Y; Bian J; Cao H
    PLoS One; 2013; 8(2):e56918. PubMed ID: 23451111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between murine double minute 2 T309G polymorphism and risk of liver cancer.
    Tang T; Song X; Yang Z; Huang L; Wang W; Tan H
    Tumour Biol; 2014 Nov; 35(11):11353-7. PubMed ID: 25119589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDM2 SNP309 polymorphism and breast cancer risk: a meta-analysis.
    Zhao E; Cui D; Yuan L; Lu W
    Mol Biol Rep; 2012 Apr; 39(4):3471-7. PubMed ID: 21725850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis.
    Peng Q; Mo C; Qin A; Lao X; Chen Z; Sui J; Wu J; Zhai L; Yang S; Qin X; Li S
    J Exp Clin Cancer Res; 2013 Nov; 32(1):85. PubMed ID: 24423195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cigarette smoking, MDM2 SNP309, gene-environment interactions, and lung cancer risk: a meta-analysis.
    Bai J; Dai J; Yu H; Shen H; Chen F
    J Toxicol Environ Health A; 2009; 72(11-12):677-82. PubMed ID: 19492228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of murine double minute 2 polymorphisms on the risk and survival of osteosarcoma: a systemic review and meta-analysis.
    Wang L; Liu Z; Jing P; Shao L; Chen L; He X; Gong W
    Tumour Biol; 2014 Feb; 35(2):1649-52. PubMed ID: 24122202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDM2 SNP309T>G polymorphism with hepatocellular carcinoma risk: a meta-analysis.
    Liu GY; Jiang DK; Shen SQ; Yu L
    Arch Med Res; 2011 Feb; 42(2):149-55. PubMed ID: 21565629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An updated meta-analysis on the association of MDM2 SNP309 polymorphism with colorectal cancer risk.
    Qin X; Peng Q; Tang W; Lao X; Chen Z; Lai H; Deng Y; Mo C; Sui J; Wu J; Zhai L; Yang S; Li S; Zhao J
    PLoS One; 2013; 8(9):e76031. PubMed ID: 24098760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDM2 309T>G polymorphism and risk of squamous cell carcinomas of head and neck: a meta-analysis.
    Liu J; Zheng Y; Lei D; Liu D; Xu F; Jin T; Cao X; Zhao X; Yu X; Pan X
    Asian Pac J Cancer Prev; 2011; 12(8):1899-903. PubMed ID: 22292622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual and combined effects of MDM2 SNP309 and TP53 Arg72Pro on breast cancer risk: an updated meta-analysis.
    Cheng H; Ma B; Jiang R; Wang W; Guo H; Shen N; Li D; Zhao Q; Wang R; Yi P; Zhao Y; Liu Z; Huang T
    Mol Biol Rep; 2012 Sep; 39(9):9265-74. PubMed ID: 22729912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review and meta-analysis of MDM2 polymorphisms in osteosarcoma susceptibility.
    Bilbao-Aldaiturriaga N; Askaiturrieta Z; Granado-Tajada I; Goričar K; Dolžan V; For The Slovenian Osteosarcoma Study Group ; Garcia-Miguel P; Garcia de Andoin N; Martin-Guerrero I; Garcia-Orad A
    Pediatr Res; 2016 Oct; 80(4):472-9. PubMed ID: 27438225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between MDM2 gene SNP309 polymorphism and susceptibility to leukemia.
    Ou WB
    Med Sci Monit; 2015 Jan; 21():213-8. PubMed ID: 25600314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of MDM2 SNP309 polymorphism on breast cancer risk along with race: a meta-analysis.
    Economopoulos KP; Sergentanis TN
    Breast Cancer Res Treat; 2010 Feb; 120(1):211-6. PubMed ID: 19590949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MDM2 SNP309T>G polymorphism increases bladder cancer risk among Caucasians: a meta-analysis.
    Wang HG; Wu QY; Zhou H; Peng XS; Shi MJ; Li JM; Zhou YF
    Asian Pac J Cancer Prev; 2014; 15(13):5277-81. PubMed ID: 25040988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of MDM2 T309G polymorphism in susceptibility and prognosis of nonsmall cell lung cancer: a meta-analysis.
    Kong Q; Li P; Tian Q; Ha MW
    Genet Test Mol Biomarkers; 2014 May; 18(5):357-65. PubMed ID: 24673452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDM2 SNP309 contributes to tumor susceptibility: a meta-analysis.
    Wo X; Han D; Sun H; Liu Y; Meng X; Bai J; Chen F; Yu Y; Jin Y; Fu S
    J Genet Genomics; 2011 Aug; 38(8):341-50. PubMed ID: 21867960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.